블로그
- Hyundai Bio’s General Antiviral Drug Zefty Offers Hope for Dengue Fever Treatment in South East Asia https://www.newsdirectory3.com/hyundai-bios-general-antiviral-drug-zefty-offers-hope-for-dengue-fever-treatment-in-south-east-asia
- Hyundai Bioscience’s XAFTY: A Breakthrough Antiviral Drug for COVID-19 and Dengue Fever https://bnn.network/finance-nav/hyundai-biosciences-xafty-a-breakthrough-antiviral-drug-for-covid-19- and-dengue-fever/ [번역] IDWEEK 2023 컨퍼런스의 대강당에는 기대에 찬 목소리가 울려 퍼졌습니다.
- (방글라데시 외신기자)현대바이오사이언스의 XAFTY: 코로나19 및 뎅기열에 대한 획기적인 항바이러스제 https://bnn.network/finance-nav/hyundai-biosciences-xafty-a-breakthrough-antiviral-drug-for-covid-19- and-dengue-fever/ 현대바이오사이언스의 XAFTY: 코로나19 및 뎅기열에 대한 획기적인 항바이러스제 무하마드 자 와드 IDWEEK 2023 컨퍼런스의 대강당에는 기대에
- Klebsiella oxytoca - hospital-acquired infection in adults - multiple drug resistance to commonly used antibiotics - All ceftriaxone was higher at 72% Resistance to ciprofloxacin and aztreonam was less (58%). - pneumonia, UTI - Fever